Showing results (221-230 of 375) with videos related to

Sort By:
Pageof 38
International Journal of Cancer|September 15, 1995
Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanomaG Ritter, E Ritter-Boosfeld, R Adluri, et al.
Glycobiology|July 24, 1998
Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterizationB Catimel, A M Scott, F T Lee, et al.
The American Journal of Cardiology|May 15, 1990
Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery diseaseA R Moosvi, S Goldstein, S VanderBrug Medendorp, et al.
Journal of Chromatography. A|July 25, 1997
Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategiesB Catimel, M Nerrie, F T Lee, et al.
The Journal of Experimental Medicine|February 24, 2000
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanomaE Jäger, D Jäger, J Karbach, et al.
The Journal of Biological Chemistry|May 2, 2000
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodiesC Rader, G Ritter, S Nathan, et al.
Cancer Research|March 1, 1990
Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3G Ritter, E Boosfeld, E Markstein, et al.
Journal of Chromatography. A|May 2, 1998
Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epitheliumR L Moritz, G Ritter, B Catimel, et al.
The New England Journal of Medicine|November 27, 1980
Use of the cardiac-catheterization laboratory in a defined populationR H Kennedy, M A Kennedy, R L Frye, et al.
Cancer Research|July 17, 2001
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFRR B Luwor, T G Johns, C Murone, et al.
Pageof 38